Virbac is a winner of the "France recovery industry” plan
2021/07/29 - Press
July 26, visit to Carros of the prefect for the nice region and the Public accounts deputy minister.
Sustainable development: strengthened commitments!
2021/07/15 - Press
New CSR indicators and GRI compliance for 10 years
Virbac ready to sell the industrial site of Magny-en-Vexin (Paris) to the company Friulchem
2021/05/25 - Press
As part of its 2030 vision, Virbac sells the ownership and activity of the Magny-en-Vexin industrial site to Friulchem, a CMO (Contract manufacturing organization) partner of Virbac for more than twenty years and specialized among others in the production of antibiotics. Following the sharp decline in demand in recent years for the type of products manufactured in Magny-en-Vexin, this option will preserve employment, the competitiveness of the site and products.
Osteoarthritis in dogs: a new breakthrough in the treatment of pain
2021/05/12 - Press
Agreement signed for the distribution in Europe of a new weekly anti-inflammatory drug.
Companion animals: Virbac takes over assets from Elanco
2021/03/01 - Press
Information following the approval of the European competition authorities
Algenex and Virbac sign international commercial licensing agreement for CrisBio®-based vaccine in major swine indication
2021/02/24 - Press
Find out the press release issued on February 23rd.
Virbac Opens Its First Research And Development Center Dedicated To Warm Water Aquaculture
2021/02/23 - Press
Today, we are inaugurating our first research and development center dedicated to warm water aquaculture in the Dong Nai province in Vietnam. Aquaculture is a rapidly growing sector, particularly in Asia, and provides an answer to the problems of feeding a world population that could reach 9 billion people in 2030. True to our mission to work for animal health, we continue to invest in order to offer new solutions for more sustainable aquaculture.
Gaia Index: Virbac progresses in the ranking!
2021/02/12 - Press
We are improving our presence in the ranking of the 70 French companies with the best ratings in terms of social and environmental responsibility.
Virbac and Symbiocelltech sign exclusive option agreement to develop novel technology for treatment of type 1 diabetes in companion animals.
2021/01/13 - Press
Discover the press release issued on january 12th
Happy season’s greetings!
2020/12/18 - Press
Discover the video of Sébastien Huron, chief executive officer of the Virbac group, for the end of the year 2020.
2020: discover 2020 overview!
2020/12/11 - Press
Ensuring the safety of our employees and maintaining our business essential to the animals' health. These are the two major challenges met in 2020 facing an unprecedented health crisis. We would like to share with you the panorama of this exceptional year on video.
Virbac partners with Ictyogroup to bring new aquaculture solutions
2020/09/17 - Press
Full details of this new partnership can be found in the joint press release issued on September 15.
Virbac Oncology Summit: veterinarians mobilize around the treatment of canine skin tumors
2020/05/13 - Press
On April 24, more than 350 veterinarians and experts attended our first scientific summit dedicated to veterinary oncology. Thanks to this exclusive online event, European and North American practitioners have been able to discover the latest scientific data and a new treatment option of canine mast cell tumors.
Carros: one of our worldwide production site of dog and cat vaccines will be stopped for at least 6 weeks
2020/05/04 - Press
Since April 11, 2020, following an underground pipeline rupture, our Bio4 dog and cat vaccine production site has been shut down. We expect to resume operations in June, after a refurbishment allowing the resumption of manufacturing under GMP (Good manufacturing practice) rules.
Covid-19: Virbac teams mobilized
2020/03/27 - Press
Since the beginning of the coronavirus outbreak, numerous measures have been taken around the world to protect the health and safety of our employees and ensure the continuity of our commitment to animal health.
Imago: a promising first assessment
2020/03/19 - Press
Today, more than ever, we are striving to make our animal health solutions even more accessible to veterinarians, farmers and animal owners around the world. This is why in 2019, we launched a pilot program in France to transform our industrial activities. A great adventure for our teams, who are mobilising all their know-how to continue to develop the Virbac production sites in terms of performance, safety and quality. Watch the 2019 achievements in video.
Pebble Labs and Virbac announce the signing of a comprehensive commercial agreement for aquaculture disease prevention
2020/03/11 - Press
Find out the press release dated March 9.
Asia: better meeting tomorrow's food needs
2020/01/30 - Press
End of November, the Virbac teams shared for one day the groundbreaking ceremony of a new research & development center in Taiwan. This site will be dedicated to the support of aquaculture and swine farming activities in Asia.
Happy new year!
2020/01/06 - Press
Sébastien Huron, chairman of the executive board of the Virbac group, wishes a happy new year for 2020 through a video.
Mexico: Virbac supports young French companies
2019/12/05 - Press
As part of the French Fab mission lead by the French public investment bank (Bpifrance), Virbac sponsors a support mission in 2019 for young French companies wishing to establish themselves in Mexico.
Jean-Pierre Dick steps down from the executive board of the Virbac group
2019/11/05 - Press
Virbac has accepted Jean-Pierre Dick’s resignation from the executive board, effective November 14, 2019.
Virbac Mexico celebrates 30 years
2019/10/11 - Press
This year marks the 30th year of Virbac’s iconic Latin American subsidiary, and they wished to celebrate the past thirty years of innovation and dedication to animal health along with their employees and customers on October 5, 2019. With a unique vision aligned to the Virbac Group’s values, the company has always taken its environmental impact and its social responsibility towards employees to heart.
Sustainable development: an ever-greater commitment
2019/06/06 - Press
As part of its 2018 annual report, Virbac published its first non-financial performance statement in April. This document marks a new stage for the Group, who is reinforcing its commitments to sustainable development.
Vietnam: a sustainable collaboration with farmers
2019/05/21 - Press
End of 2018, the Virbac Husbandry Club in Vietnam, which helps pig and poultry farmers tackle local animal health issues, celebrated 10 years of activity. This 10th anniversary is a testament to the Group’s drive to carry out sustainable actions that promote improvement in farming conditions.
Innovation: the Smart Cap “all in one” is rewarded again!
2019/03/20 - Press
Each year, the ADF Paris awards honor the packaging innovations of the global aerosol and dispensing industries. Last January, the Virbac Smart Cap "all-in-one", already awarded in 2018 by Pharmapack, received the prize for the best innovation in the "Pharmacy" category.
Happy new year!
2019/01/10 - Press
Sébastien Huron, chairman of the executive board of the Virbac group, wishes all the best for 2019 through a video.
Virbac websites: make the access to information easier
2018/12/21 - Press
In 2018, several Virbac websites were revamped: new contents, new design, new functionalities… all these changes aim at creating a better user experience.
Gaïa Index: Virbac ranked again in 2018!
2018/11/13 - Press
In 2018, Virbac is part of the Gaïa Index, which recommends the 70 French companies with the best ratings in terms of social and environmental responsibility among a panel of 230 firms. Virbac has made a significant improvement of 14 places in the overall ranking compared to 2017.
Turkey: Virbac closer to the field
2018/10/23 - Press
After a twenty-year presence in Turkey through a local distributor, Virbac is creating its 33rd subsidiary there. The objective: closer proximity in order to better respond to the expectations of animal health players.
Virbac wins the Pharmapack Award with its “all-in-one” Smart Cap
2018/06/12 - Press
After five years of research and development, Virbac teams have developed Smart Cap, dedicated to extracting liquid products. This patented innovation benefitting animal health, which combines ergonomics and safety, was recognized in early 2018 with a Pharmapack Award.
Happy new year!
2018/01/08 - Press
For 2018, find out the video wishes from Sébastien Huron, new chairman of the executive board of the Virbac group.
China: Virbac acclaimed by the largest pet owners community
2017/12/05 - Press
In August 2017, Virbac was awarded pet owner favorite brand for cat health care by Goumin.com, the largest online Chinese pet owner community.
Virbac signs a research agreement with Bio-Gene
2017/06/16 - Press
Bio-Gene announces collaboration agreement with Virbac for development of FLAVOCIDE™ as an insect control agent in ruminants.
Virbac United States selects KC Animal Health Corridor for North American distribution center
2017/05/04 - Press
The Virbac American subsidiary decided to gather its distribution operations in Hunt Midwest SubTropolis (Missouri). The new center should be operational until the end of the year.
Supporting innovation through public research
2017/03/31 - Press
Public-private transfer (TPP). Behind this acronym lies the possibility for French companies to develop partnerships with French and European public research organizations. This opportunity for innovation was seized on by Virbac in 2009 and presented by the public research partnerships manager.
e-visit: always closer to veterinarians
2017/02/27 - Press
In September 2016, on the initiative of the IT department, e-visits first appeared amongst the sales force in France. The purpose: allow greater reactivity from regional technical managers to questions from veterinarians. Explanations on this European-scale project by the market manager for Virbac France.
"Factories and Men" Exhibition: Virbac at the forefront!
2016/10/08 - Press
14 September 2015, Paris. The "Factories and Men" operation is being organised by 'Mouvement des entreprises de taille intermédiaire' (METI), an organisation which represents intermediate-sized businesses in France. The project began with a preview at the Petit Palais, and METI has organised a series of events which will take place until the end of 2015 with the aim of spotlighting the best of French industry. Thirty five businesses, including Virbac, are taking part.
Sustainable development: a new step
2016/07/28 - Press
In its 2015 report, Virbac adopted the most recent version of the GRI standard for sustainable development. The reasons behind this change and the related benefits explained by Éric Marée, chairman of the executive board.
USA: Virbac creates 144 jobs in Bridgeton, Missouri
2016/04/13 - Press
Virbac is investing $37.9 millions in its production site in Bridgeton, Missouri.
Instrucciones: a new high quality facility
2016/03/17 - Press
A 3,600 m² space dedicated to production! At the end of September the new Instrucciones site was opened in Uruguay, with a special emphasis on quality. An introduction to this leading edge facility by the subsidiary’s general manager.
New tagline: Virbac shows its ambition!
2016/03/12 - Press
“Shaping the future of animal health”. This is now Virbac's new tagline, replacing “Passionate about animal health”, launched in 2001.
What message does this new slogan convey? Answers from Sandrine Brunel, head of Corporate Communications.
VDS: Virbac's commitment to the dairy sector
2016/02/20 - Press
At the beginning of October the GMBO (Global Marketing) organized the first Virbac Dairy Symposium in France, attended by experts from the dairy sector and Virbac staff from all over the world. Fabrice Payot, Global Marketing manager on the dairy cattle segment, explains the objectives of this major event.
St. Louis: to better serve product innovation
2015/01/09 - Press
Virbac United States inaugurates the April 20th, 2014 a new building for its R&D activities. With which objectives? The answers from R&D vice-president of the American subsidiary.